Sponsor:
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Code:
NCT06856174
Conditions
HIV Infection
Menopause
Eligibility Criteria
Sex: Female
Age: 40 - 60
Healthy Volunteers: Not accepted
Interventions
Transdermal estradiol gel
Micronized Progesterone
Placebo for estradiol gel
Placebo for micronized progesterone
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-01. This information was provided to ClinicalTrials.gov by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections on 2026-05-22.